EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS182-01187 
Organism
Homo sapiens 
Tissue/cell
Spleen 
Coordinate
chr1:108418390-108419330 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
TP63MA0525.2chr1:108419053-108419071AAGATGTCGAGACATGTT+6.14
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_10900chr1:108400203-108420970CD20
SE_25637chr1:108418521-108420863DND41
SE_39364chr1:108415894-108420618Jurkat
SE_49834chr1:108413139-108423298RPMI-8402
SE_58785chr1:108402920-108444499Ly1
SE_66242chr1:108415894-108420618Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1108418505108419000
Number: 1             
IDChromosomeStartEnd
GH01I107876chr1108419023108419222
Enhancer Sequence
GCTAGGGTGG AGGCAGGAAA ACCAGACATA AGGCTCTTGC AATAACCCAG GTGAGAGACA 60
ACTGTGGGAA GACCAGAGTG TGGTCACTTT TTGACTGTGT TAAATCTGAG AGGCCTATTA 120
GTCATCCAAT AAGTGTGGAG TCCAGGGGAT AGGTGTGTAC TTCAGACAGA AATATGGGAG 180
TCTTTAGTGT ACAGAGGACT GTTAACCATG ACACTGGCTG AAATGACTGT GGAATAGAGC 240
AAAGAAGAGG AGAGTACCTG AGCCAGGAAA CTTTAAAGGA TCAGGAAAAG AGGAGGAGCT 300
CACAAAGGAG TCTTAGTAAG AGTGACCAGT TAGGAAGTAG GAAAACCAGG AGATAGGGTT 360
TTCCTGAAGC CAAGTAAAGA ATGTGTTTCT AGATGAAGGG AGTGAAAAAC TATATCAGAT 420
GCTGCAGACG GCCAAATAGG ATTTAGACCA ACGGATTGGT CAACACTGCC CATGGATTCT 480
GGCAGTGTGA AAGTCACGGG TACCTTGACA AAAGCAGGCT CTATATGGAG GAGTGGGATG 540
AAAGGCCTCT TGGAGTTGGT TTCAGAGACA AAGAGAGAAA AGGAAGTGAA GACAGAATAT 600
AGACTCCTGA GTTTTGCTGC AGAGGAGAAC AGAGAAATGG TCAAGAGTTT TAAGAAACAG 660
CAGAAGATGT CGAGACATGT TTCTGTTTTG ATGGGAATAA CCTGATAGAG AGGGGAAAGC 720
TGGTAACAAA GCAGAGAAGG ACAGTTCCCC AAATGTAGTC CTGATTAGGT GAAGTGGGGA 780
GAGATCAAGT GTTTAAGTGC AGCAGCTGAC CTTAGAGAAG AGCATGGTCA ACTCATCCAC 840
ACTATAACAG GGAGATAGGA GGGAAGGCAG ACACTACTGA CTACTTAAAA AAACAAAAGT 900
TAAAATTTGC TTTCAGTGTC TAAAAGACTC AGATCCACCT 940